All eyes set on the game-changing oral pill and two new vaccines to fight off COVID in India
As the country is witnessing a new surge in the cases of COVID, states have started imposing lockdowns. The scientists ...
ADVERTISEMENT
Tag: Covaxin
In The Real World Study, Covaxin shows only 50% efficacy against symptomatic COVID-19:
In the real-world study done by Lancet Infectious Disease, BBV152 or Covaxin Indigenously produced vaccine showed only 50% efficacy against ...
96 countries have accepted and conceded both Indian vaccines- Covishield and Covaxin.
On Tuesday, the Union Health Minister of India, Mansukh Mandaviya announced the indigenous anti-Covid-19 vaccines…
UPDATE ON VACCINE IN INDIA AND WORLD
Covaxin approved for emergency use for children between 2-18 years.
TSA Fact Check: Viral Social Media Posts Claim Vaccination Is Behind The Development Of New COVID Strain – FALSE
THE CLAIM COVID-19 vaccines are creating virus variants This began after a Facebook post containing an article published in the ...
In India vaccination drive jumps four fold as Prime Minister is inoculated
The data shows almost 21 million shots have been administered in India so far, with a record of 1.6 million ...
AMU VC registered himself as the first volunteer for phase-3 clinical trial of Covaxin
AMU VC Prof. Tariq Mansoor enrolled himself as the first volunteer for the Covaxin phase-3 trial by Bharat Biotech which ...
ICMR steps ahead to launch the COVID-19 Vaccine ‘Covaxin’ by 15 August, receives criticism from the scientific community
While the first vaccine globally to go into human trials, developed by US-based Moderna Inc. is still in its second ...
The Second Angle (TSA) Magazine covers a broad spectrum of topics including Entertainment, Lifestyle, education, Crypto, iGaming, Technology, fashion, beauty, relationships, celebrities, wellness, travel, and food. It also features user-generated content in the form of tips, guest post, forums, polls, contests and other interactive articles.